Connect with us

Hi, what are you looking for?

Thursday, Oct 6, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

PharmaCielo receives certification to start exporting pot to Israel

The company expects to start exporting early next year

PharmaCielo receives certification to start exporting pot to Israel
Photo via PharmaCielo

 PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) is set to start exporting pot to Israel as early as next year after receiving certifications from Israeli authorities.

On Friday, the cannabis producer headquartered in Toronto but with primary operations in Rio Negro, Colombia said it has been certified by the Institute of Quality and Control (IQC) of Israel and received ICANN G.A.P. and GACP certifications and passed all audits at its facilities.

Israel is one of the largest importers of medical cannabis in the world, with 109,352 patients who used cannabis in 2021 which is a 35 per cent increase from 2020.

Read more: PharmaCielo ships pre-commercial CBD isolate to Mexican pharmaceutical

Read more: PharmaCielo announces new supply agreement with Brazilian firm

“The receipt of ICANN G.A.P and GACP certifications from IQC is a significant milestone for PharmaCielo and is complimentary to the previously obtained INVIMA GMP and SGS GACP certifications, which enable access to other highly regulated markets, such as Brazil,” said PharmaCielo CEO Bill Petron adding that Israel is a massive opportunity for the company.

“The country has a large, rapidly growing patient population and relies heavily on imports. We expect that PharmaCielo’s proprietary Colombian genetics will differentiate the company’s offerings compared to the current products available in the Israeli market.”

“Our team has already connected with some of the most important players in Israel, and we expect to begin shipping commercial quantities of dried flower in early 2023,” Petron said.

The company is expecting to receive its EU-GMP certifications for its extracts and for its flower.

PharmaCielo grows all its cannabis at the facilities of its subsidiary PharmaCielo Colombia Holdings S.A.S. in Colombia and has started supplying cannabis products to other markets such as Brazil and Mexico.

Company stock went down on Friday by 6.73 per cent to $0.48 on the Canadian Ventures Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

 

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Business

The firm has sent its product to different markets worldwide including Germany, Israel, Brazil, Mexico, Poland and now the Czech Republic

International

Innovative new studies in the Middle East receive approval from Israeli Ministry of Health

Business

The isolate will go to MINO Labs, a specialty pharma and medical supply distributor

Business

The multinational also announced a couple of leadership updates